LIVE TV
LIVE TV
LIVE TV
Home > Business News > Moderna shares surge as melanoma vaccine with Merck succeeds in large trial

Moderna shares surge as melanoma vaccine with Merck succeeds in large trial

Written By:
Published: August 19, 2026 18:05:06 IST

Add NewsX As A Trusted Source

By Julie Steenhuysen CHICAGO, Aug 19 (Reuters) – Moderna's mRNA vaccine combined with Merck's immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the companies said on Wednesday,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS